Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DCTHNASDAQ:MODDNYSE:NVRONASDAQ:SMLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCTHDelcath Systems$12.73+1.7%$14.73$7.17▼$18.23$435.68M0.87422,992 shs372,796 shsMODDModular Medical$0.73+4.1%$0.87$0.63▼$2.65$37.97M0.17219,972 shs360,021 shsNVRONevro$5.85+0.1%$5.85$3.17▼$10.37$224.32M0.81797,136 shs753,602 shsSMLRSemler Scientific$39.70+0.4%$36.55$21.77▼$81.56$440.93M1.39554,985 shs298,843 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCTHDelcath Systems+1.72%-9.43%-20.86%+15.58%+60.87%MODDModular Medical+4.14%+12.33%-16.90%-17.16%-47.93%NVRONevro0.00%0.00%0.00%0.00%-30.24%SMLRSemler Scientific+0.40%+2.35%+11.58%+17.28%+21.67%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDCTHDelcath Systems3.6292 of 5 stars3.55.00.00.02.72.50.6MODDModular Medical0.5784 of 5 stars0.05.00.00.00.01.70.0NVRONevro0.1869 of 5 stars1.00.00.00.00.01.70.6SMLRSemler Scientific1.8663 of 5 stars3.52.00.00.00.62.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDCTHDelcath Systems 3.00Buy$24.0088.61% UpsideMODDModular Medical 0.00N/AN/AN/ANVRONevro 1.92Reduce$5.36-8.29% DownsideSMLRSemler Scientific 3.00Buy$71.0078.84% UpsideCurrent Analyst Ratings BreakdownLatest MODD, NVRO, SMLR, and DCTH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/23/2025DCTHDelcath SystemsStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$25.005/23/2025DCTHDelcath SystemsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$24.00 ➝ $29.00(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDCTHDelcath Systems$37.21M11.91N/AN/A$2.15 per share5.92MODDModular MedicalN/AN/AN/AN/A$0.42 per shareN/ANVRONevro$408.52M0.55N/AN/A$8.10 per share0.72SMLRSemler Scientific$56.29M7.86$4.50 per share8.83$24.90 per share1.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDCTHDelcath Systems-$26.39M-$0.50N/AN/AN/A-26.38%-29.44%-20.75%8/4/2025 (Estimated)MODDModular Medical-$18.82M-$0.51N/A∞N/AN/A-178.13%-151.42%8/12/2025 (Estimated)NVRONevro-$92.21M-$3.05N/AN/AN/A-16.54%-23.52%-10.83%8/4/2025 (Estimated)SMLRSemler Scientific$40.90M-$2.61N/A∞N/A-60.69%19.75%15.47%8/4/2025 (Estimated)Latest MODD, NVRO, SMLR, and DCTH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/20/2025Q4 2025MODDModular Medical-$0.11-$0.12-$0.01-$0.12N/AN/A5/13/2025Q1 2025SMLRSemler ScientificN/A-$0.76N/A-$6.74N/A$8.84 million5/8/2025Q1 2025DCTHDelcath Systems$0.10$0.03-$0.07$0.03$16.83 million$19.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDCTHDelcath SystemsN/AN/AN/AN/AN/AMODDModular MedicalN/AN/AN/AN/AN/ANVRONevroN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDCTHDelcath SystemsN/A15.9514.61MODDModular MedicalN/A10.6910.69NVRONevro0.675.023.76SMLRSemler Scientific0.590.520.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDCTHDelcath Systems61.12%MODDModular Medical27.47%NVRONevro95.52%SMLRSemler Scientific49.37%Insider OwnershipCompanyInsider OwnershipDCTHDelcath Systems17.40%MODDModular Medical20.46%NVRONevro3.20%SMLRSemler Scientific30.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDCTHDelcath Systems6034.83 million28.77 millionOptionableMODDModular Medical2054.25 million43.15 millionNot OptionableNVRONevro1,09038.37 million36.27 millionOptionableSMLRSemler Scientific12011.15 million7.78 millionNot OptionableMODD, NVRO, SMLR, and DCTH HeadlinesRecent News About These CompaniesSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 2 at 3:18 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJuly 2 at 10:00 AM | prnewswire.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJuly 1 at 3:46 PM | prnewswire.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 27, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 27, 2025 | prnewswire.comSemler Scientific Trades at Premium to Bitcoin Holdings for First Time in Three WeeksJune 26, 2025 | finance.yahoo.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 25, 2025 | prnewswire.comWhy the company behind a controversial medical device just pivoted — to bitcoinJune 25, 2025 | statnews.comSSMLR - Semler Scientific Inc Chart - MorningstarJune 24, 2025 | morningstar.comMSemler Scientific® Announces CardioVanta™, a New Entity that Seeks to Unlock Value of Future Medical Business OpportunitiesJune 24, 2025 | prnewswire.comFrom boom to bitcoin: A device maker’s surprising pivot amid a Medicare crackdownJune 24, 2025 | statnews.comSSemler Scientific Plans to Hold 105,000 Bitcoins by 2027June 23, 2025 | livebitcoinnews.comLINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 23, 2025 | globenewswire.comShariaportfolio Inc. Sells 55,650 Shares of Semler Scientific Inc. (NASDAQ:SMLR)June 23, 2025 | marketbeat.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 22, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 22, 2025 | prnewswire.comSemler Scientific Inc. (NASDAQ:SMLR) Shares Acquired by GAMMA Investing LLCJune 22, 2025 | marketbeat.com Bitcoin in a post-Trump world worries hedge fund execs: Eric Semler June 21, 2025 | cointelegraph.comSemler Scientific Ramps Up Bitcoin Strategy 105K BTC Target SetJune 21, 2025 | thecurrencyanalytics.comTNews Explorer — Semler Scientific Stock Rises on Bitcoin Buying Plans, BTC Director HireJune 20, 2025 | decrypt.coDRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 20, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMODD, NVRO, SMLR, and DCTH Company DescriptionsDelcath Systems NASDAQ:DCTH$12.72 +0.22 (+1.72%) Closing price 07/3/2025 03:29 PM EasternExtended Trading$12.87 +0.15 (+1.17%) As of 07/3/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.Modular Medical NASDAQ:MODD$0.73 +0.03 (+4.14%) As of 07/3/2025 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.Nevro NYSE:NVRO$5.85 +0.01 (+0.10%) Closing price 04/2/2025Extended Trading$5.85 0.00 (0.00%) As of 04/2/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.Semler Scientific NASDAQ:SMLR$39.70 +0.16 (+0.40%) Closing price 07/3/2025 03:54 PM EasternExtended Trading$39.70 0.00 (0.00%) As of 07/3/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
